Cite
MLA Citation
Gilbert L'Italien et al.. “Rimegepant 75 mg for acute treatment of migraine is associated with significant reduction in monthly migraine days: Results from a long-term, open-label study.” Cephalalgia reports, vol. 5, 2022, p. . http://access.bl.uk/ark:/81055/vdc_100169725485.0x000006